S-nitrosoglutathione prevents cognitive impairment through epigenetic reprogramming in ovariectomised mice

Biochemical Pharmacology
Aanchal AggarwalVikas Rishi

Abstract

The epigenetic signatures associated with cognitive decline driven by lack of estrogen in post-menopausal state, is not well-understood. The present study is an attempt to unravel the epigenetic mechanisms involved in cognitive impairment preceding ovariectomy in mice and evaluate the protective effects of S-nitrosoglutathione (GSNO). A significant decline in cognitive functions was observed in mice following ovariectomy as assessed by Morris water maze and Novel object recognition test. Administration of GSNO (100 µg/kg body weight, orally) daily for 4 weeks was found to ameliorate cognitive deficits observed in ovariectomised (OVX) mice. The activity of histone acetyl-transferase (HAT) was significantly disrupted in cortex and hippocampus of OVX mice. This was accompanied by increased activity of histone deacetylase (HDAC) and increased levels of HDAC-2, HDAC-3 causing lowered acetylated histone (H)3 levels. Reduced H3 acetylation triggers epigenetic repression of brain derived neurotrophic factor (BDNF) in cortex and hippocampus of OVX mice that may be responsible for neuronal damage and cognitive impairment. GSNO supplementation to OVX mice was able to reinstate HAT(CBP/p300) and HDAC balance through S-nitrosylation. GSNO r...Continue Reading

References

May 1, 1984·Journal of Neuroscience Methods·R Morris
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·F SohrabjiC D Toran-Allerand
Feb 17, 2000·Journal of the National Cancer Institute·R K RossM C Pike
Jul 14, 2006·Biochemical Pharmacology·A S QuinaL Di Croce
Nov 14, 2006·Neurobiology of Aging·K YaffeUNKNOWN Health ABC Investigators
Dec 7, 2006·Journal of Neuroscience Research·Tamara AidTõnis Timmusk
Jun 8, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christopher G VecseyMarcelo A Wood
Sep 7, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tangui MauriceCéline Gongora
Jul 24, 2008·Metabolic Brain Disease·Siomara C MonteiroAngela T S Wyse
Oct 2, 2008·Nature Reviews. Drug Discovery·Aleksey G Kazantsev, Leslie M Thompson
Dec 3, 2008·Proceedings of the National Academy of Sciences of the United States of America·Claudia ColussiCarlo Gaetano
Nov 17, 2009·Cardiovascular Research·Subhadeep ChakrabartiSandra T Davidge
Mar 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Zaorui ZhaoKaryn M Frick
Sep 4, 2010·Antioxidants & Redox Signaling·Neelam Shahani, Akira Sawa
Nov 26, 2010·PloS One·Kathleen Brown-SteinkeLisa A Palmer
Feb 16, 2011·Journal of Molecular Endocrinology·Xiang Zhang, Shuk-Mei Ho
Apr 30, 2011·Physiological Reviews·Johannes GräffLi-Huei Tsai
Jun 7, 2011·Biochimica Et Biophysica Acta·Yonggang Sha, Harvey E Marshall
Oct 19, 2011·Behavioral Neuroscience·Barbara B Sherwin
Dec 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan ZengCui-Wei Xie
Mar 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Farideh BeigiJoshua M Hare
Mar 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zaorui ZhaoKaryn M Frick
Feb 19, 2013·Biochimica Et Biophysica Acta·Katarzyna A BroniowskaNeil Hogg
Jun 8, 2013·ILAR Journal·Kathryn Gudsnuk, Frances A Champagne
Sep 14, 2013·Journal of Neuroendocrinology·K M Frick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.